Identification of markers of prostate cancer progression using candidate gene expression

BACKGROUND: Metastatic prostate cancer (PCa) has no curative treatment options. Some forms of PCa are indolent and slow growing, while others metastasise quickly and may prove fatal within a very short time. The basis of this variable prognosis is poorly understood, despite considerable research. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Larkin, S E T, Holmes, S, Cree, I A, Walker, T, Basketter, V, Bickers, B, Harris, S, Garbis, S D, Townsend, P A, Aukim-Hastie, C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3251845/
https://www.ncbi.nlm.nih.gov/pubmed/22075945
http://dx.doi.org/10.1038/bjc.2011.490

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3251845/
https://www.ncbi.nlm.nih.gov/pubmed/22075945
http://dx.doi.org/10.1038/bjc.2011.490

Ejemplares similares